BICO Group AB Class B CLLKF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.51
- Day Range
- $2.40–2.40
- 52-Week Range
- $1.52–2.56
- Bid/Ask
- $1.02 / $3.36
- Shares Outstanding
- 70.57M
- Market Cap
- $169.38M
- Volume/Avg
- 428 / 1,349
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.07
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 554
- Website
- https://www.bico.com
Valuation
|
Metric
|
CLLKF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.05 |
Price/Sales | 1.07 |
Price/Cash Flow | 55.18 |
Price/Earnings
CLLKF
Financial Strength
|
Metric
|
CLLKF
|
|---|---|
Quick Ratio | 1.85 |
Current Ratio | 2.42 |
Interest Coverage | −11.69 |
Quick Ratio
CLLKF
Profitability
|
Metric
|
CLLKF
|
|---|---|
Return on Assets (Normalized) | −7.30% |
Return on Equity (Normalized) | −14.15% |
Return on Invested Capital (Normalized) | −7.15% |
Return on Assets
CLLKF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|y<^>P#T | LOCK|K!Yy | $179B | |||
| Medtronic PLC
MDT
| LOCK|$GqQQf | LOCK|&Qqpb | $122B | |||
| Stryker Corp
SYK
| LOCK|^%R<$WSv | LOCK|@K | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|tK%S%@@ | LOCK|JN$t | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|!LQ^Nf@? | LOCK|GY?P | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$vvP!> | LOCK|>H | $32B | |||
| DexCom Inc
DXCM
| LOCK|vWvs@<l | LOCK|jcFS | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|!Hr | LOCK|SG | $26B | |||
| Steris PLC
STE
| LOCK|rBCkxt | LOCK|@^hW | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|gQ?dzmF^ | LOCK|$&Q | $19B |
United States